US Stock MarketDetailed Quotes

ATOS Atossa Therapeutics

Watchlist
  • 1.3000
  • 0.00000.00%
Close May 31 16:00 ET
  • 1.3500
  • +0.0500+3.85%
Post 18:05 ET
163.48MMarket Cap-5416P/E (TTM)

Atossa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atossa Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.05

0.00%
Analyst Rating

Strong Buy

May 31, 2024

Atossa Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
Aug 14, 20232023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
Aug 14, 20232023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Atossa Therapeutics Earnings Reports

  • Atossa Therapeutics | 10-Q: Quarterly report

    May 13 09:09 ET

  • Atossa Therapeutics | 10-K: Annual report

    Apr 1 16:09 ET

  • Atossa Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 09:10 ET

  • Atossa Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 08:35 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg